The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 8th 2024
A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
COVID-19 Pandemic May Have Worsened Racial Disparities in Wait Times for Specialty Consults
January 23rd 2023A new study from clinicians in the VA Boston Healthcare System provides an overview of the impact the COVID-19 pandemic has had on racial disparities in wait times for new cardiology and orthopedic specialist consultations.
Analysis Provides Updated Overview of Risk with Mitral Valve Repair for Mitral Regurgitation
January 20th 2023An analysis of data from the STS Adult Cardiac Surgery Database provides an updated overview of the risks of mortality, morbidity, and conversion-to-replacement among patients undergoing mitral valve repair for primary mitral regurgitation.
New AHA Statement Stresses Need for Rapid Evaluation of Transient Ischemic Attack
January 19th 2023Stroke symptoms that disappear in under an hour need emergency assessment to help prevent a full-blown stroke. A new scientific statement from the AHA provides guidance and a standardized approach to evaluating people with suspected TIA, particularly in rural areas.
Impact of Traditional Stroke Risk Factors on Stroke Risk Lessens Over Time, Study Finds
January 19th 2023An analysis of patient data from the REGARDS cohort suggests the increase in relative risk observed with traditional risk factors, such as hypertension and diabetes, on risk of stroke decreases as patients age, but investigators point out this does not diminish the importance of addressing these risk factors.
Despite Improved Screening and Rates of Dyslipidemia, Prescribing Not Yet at Optimal levels
January 13th 2023An analysis of NHANES data from 1999-2018 details the progress made with regard to cholesterol management on a population level but also provides insight into areas where room for improvement still exists.
Cardiology Case Report: Missed Dialysis
January 11th 2023In this case report, a man in his 50s with a history of ESRD, alcoholic cirrhosis, and anemia presents to the emergency department for evaluation of generalized weakness after missing his last 2 dialysis appointments. Check out the ECG and determine the most likely cause of the rhythm!
Heart Failure Risk Stratification Benefited Clinical Decision Making in Emergency Department
January 7th 2023The COACH trial reported a hospital-based strategy led to lower risk of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care in patients with acute heart failure.
More Than 1-in-4 Cardiologists Report Mental Health Conditions, Survey Finds
January 6th 2023Data from a 2019 survey of more than 5000 cardiologists across the globe suggests 28% of the field may be experiencing some form of mental health condition, with results also shedding light on predictors of mental health conditions.
SGLT2 Inhibitors Can Reduce Cardiometabolic Risk in People with Diabetes Using Metformin
January 6th 2023Using data from more than 55,000 people with diabetes using metformin is providing new insight into the apparent reductions in risk of negative cardiovascular and renal outcomes as well as all-cause mortality with use of SGLT2 inhibitors.
EVOLUTION HF Provides Overview of Global Trends in GDMT Use for Heart Failure
January 5th 2023Using real-world data from the US, Japan, and Sweden provides insight into contemporary trends in GDMT use, including initiation, uptitration, and discontinuation, following hospitalization among patients with heart failure with reduced ejection fraction.